Cargando…

Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design

Accurate antiviral humoral and cellular immune responses require prior recognition of antigenic peptides presented by human leukocyte antigen (HLA) class I and II molecules on the surface of antigen-presenting cells. Both the helper and the cytotoxic immune responses are critical for the control and...

Descripción completa

Detalles Bibliográficos
Autores principales:	López, Daniel, Barriga, Alejandro, Lorente, Elena, Mir, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518116/ https://www.ncbi.nlm.nih.gov/pubmed/30974886 http://dx.doi.org/10.3390/jcm8040486

Ejemplares similares

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence
por: Lorente, Elena, et al.
Publicado: (2019)

Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus
por: de la Sota, Patricia G., et al.
Publicado: (2021)

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

Concerted In Vitro Trimming of Viral HLA-B27-Restricted Ligands by Human ERAP1 and ERAP2 Aminopeptidases
por: Lorente, Elena, et al.
Publicado: (2013)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Immunoproteomics: The Key to Discovery of New Vaccine Antigens Against Bacterial Respiratory Infections
por: Dennehy, Ruth, et al.
Publicado: (2012)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Epidemiology, Molecular Epidemiology and Evolution of Bovine Respiratory Syncytial Virus
por: Sarmiento-Silva, Rosa Elena, et al.
Publicado: (2012)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
por: Moin, Abu Tayab, et al.
Publicado: (2023)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
por: Kim, Joo Young, et al.
Publicado: (2016)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

A Common Minimal Motif for the Ligands of HLA-B*27 Class I Molecules
por: Barriga, Alejandro, et al.
Publicado: (2014)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
por: Jorquera, Patricia A., et al.
Publicado: (2016)

Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population
por: Stephens, Laura M., et al.
Publicado: (2021)

Respiratory syncytial virus is an “opportunistic” killer
por: Caballero, Mauricio T., et al.
Publicado: (2018)

Towards the Immunoproteome of Neisseria meningitidis
por: Mendum, Tom A., et al.
Publicado: (2009)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Potential Vaccine Targets against Rabbit Coccidiosis by Immunoproteomic Analysis
por: Song, Hongyan, et al.
Publicado: (2017)

Immunoproteomic Analysis of Human Serological Antibody Responses to Vaccination with Whole-Cell Pertussis Vaccine (WCV)
por: Zhu, Yong-Zhang, et al.
Publicado: (2010)

Need for a safe vaccine against respiratory syncytial virus infection
por: Kim, Joo-Young, et al.
Publicado: (2012)

Respiratory Syncytial Virus Pediatric Hospitalization in the COVID-19 Era
por: Bozzola, Elena, et al.
Publicado: (2022)

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
por: Tripp, Ralph A., et al.
Publicado: (2019)

Attenuated Respiratory Syncytial Virus Vaccines in Asthmatic Children
por: Mcintosh, Kenneth, et al.
Publicado: (1974)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Respiratory syncytial virus infection: an innate perspective
por: Johansson, Cecilia
Publicado: (2016)

Respiratory syncytial virus: diagnosis, prevention and management
por: Barr, Rachael, et al.
Publicado: (2019)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmssri6v3g278to6qfg82h12rf